66 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional … or underwriter for any other “at the market” or continuous equity transaction.
(uu) Compliance with Health Care Laws. The Company and its subsidiaries
D
mb6p6jh
11 May 22
$15M in equity / options / securities to be acquired, sold $15M, 2 investors
3:42pm
8-K
EX-10.1
aqz61gi99rpiguo8zxd
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
PRE 14A
pbwra5o
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-1.1
ylw9n13
23 Jul 21
Other Events
5:20pm
8-K
EX-99.1
4mb3ctaxp 70dsmkf
16 Jul 21
Other Events
4:31pm